Boardroom Alpha
Boardroom Alpha
MLM · Current Report (Form 8-K) · Filed January 2, 2026

Martin Marietta Materials Inc — Current Report (Form 8-K)

Form
8-K
Filed
January 2, 2026
Period
Dec 31, 2025
Ticker
MLM
Accession
0000950157-25-001042
Boardroom Alpha · Filing insights

Martin Marietta now expects to close the Quikrete asset exchange in Q1 2026, subject to remaining closing conditions.

About Martin Marietta Materials Inc
Market cap
$34.6B
1Y TSR
+5.7%
3Y TSR
+10.7%
Board grade
C+
Sector
Basic Materials
CEO
C Howard Nye
Last annual meeting: May 14, 2026 · View full Martin Marietta Materials Inc profile →

falseMARTIN MARIETTA MATERIALS INC000091607600009160762023-11-202023-11-20falseMARTIN MARIETTA MATERIALS INC000091607600009160762023-12-212023-12-21falseMartin Marietta Materials Inc.00009160764123 PARKLAKE AVERALEIGHNYSE00009160762024-12-202024-12-20falseMartin Marietta Materials Inc.0000916076NC4123 PARKLAKE AVERALEIGHNC00009160762025-12-192025-12-19



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549



FORM 8-K



CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 31, 2025

Martin Marietta Materials, Inc.
(Exact name of Registrant as Specified in Its Charter)

North Carolina
(State or Other Jurisdiction of Incorporation)
001-12744
(Commission File Number)
56-1848578
(IRS. Employer Identification No.)

4123 Parklake Avenue
Raleigh, North Carolina
(Address of Principal Executive Offices)
 
27612
(Zip Code)

Registrant’s Telephone Number, Including Area Code: 919 781-4550

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange
on which registered
Common Stock, $0.01 par value per share
MLM
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





Item 7.01.  Regulation FD Disclosure.
 
On December 31, 2025, Martin Marietta Materials, Inc. (“Martin Marietta” or the “Company”) provided an update on the anticipated timing for closing its previously announced asset exchange with Quikrete Holdings, Inc. (“Quikrete”). As announced on October 2, 2025, the Company had expected to close the transaction in the fourth quarter of 2025, subject to customary closing conditions. The Company now expects the transaction to close in the first quarter of 2026 subject to satisfaction of the remaining customary closing conditions.
 
The information furnished under this Item 7.01 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information furnished under this Item 7.01 shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
 


Forward-Looking Statements
 
This Current Report on Form 8-K contains forward-looking statements within the meaning of federal securities law. Statements and assumptions on future revenues, income and cash flows, performance and economic trends are examples of forward-looking statements. Numerous factors could affect the Company’s forward-looking statements and actual performance.
 
Investors are cautioned that all forward-looking statements involve risks and uncertainties, and are based on assumptions that the Company believes in good faith are reasonable at the time the statements are made, but which may be materially different from actual results. Investors can identify these statements by the fact that they do not relate only to historical or current facts. The words “may”, “will”, “could”, “should”, “anticipate”, “believe”, “estimate”, “expect”, “forecast”, “intend”, “outlook”, “plan”, “project”, “scheduled” and other words of similar meaning in connection with future events or future operating or financial performance are intended to identify forward-looking statements. Any or all of Martin Marietta’s forward-looking statements in this Form 8-K and in other publications may turn out to be wrong.
 
Statements regarding the pending Quikrete transaction contain forward-looking statements that are subject to risks and uncertainties. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results may differ materially from those expressed or implied due to various factors including, but not limited to: the ability to satisfy closing conditions, transaction costs, integration challenges, market conditions, the impact of the pending transaction on the Company’s stakeholders, and other risks described in the Company’s U.S. Securities and Exchange Commission (“SEC”) filings.
 
You should consider these forward-looking statements in light of risk factors discussed in Martin Marietta’s Annual Report on Form 10-K for the year ended December 31, 2024, and other periodic filings made with the SEC. All of the Company’s forward-looking statements should be considered in light of these factors. In addition, other risks and uncertainties not presently known to the Company or that it considers immaterial could affect the accuracy of its forward-looking statements, or adversely affect or be material to the Company. The Company assumes no obligation to update any such forward-looking statements, except as may be required by law.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

Date: December 31, 2025
MARTIN MARIETTA MATERIALS, INC.
   
 
By:
/s/ Bradley D. Kohn
 
   
Name:
Bradley D. Kohn
 
   
Title:
Senior Vice President, General Counsel and Corporate Secretary
 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Martin Marietta Materials Inc (MLM)

Reference

Frequently asked questions

When did Martin Marietta Materials Inc file this 8-K?
Martin Marietta Materials Inc (MLM) filed this Current Report (Form 8-K) with the SEC on January 2, 2026. The accession number assigned by EDGAR is 0000950157-25-001042.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Martin Marietta now expects to close the Quikrete asset exchange in Q1 2026, subject to remaining closing conditions. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Martin Marietta Materials Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Martin Marietta Materials Inc has filed under CIK 916076, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer